Results 21 to 30 of about 19,554 (254)

Nontuberculous Mycobacteria as Sapronoses: A Review

open access: yesMicroorganisms, 2022
Mycobacteria are a unique group of microorganisms. They are characterised by exceptional adaptability and durability. They are capable of colonisation and survival even in very unfavourable conditions. In addition to the well-known obligate human pathogens, Mycobacterium tuberculosis and M. leprae, more than 200 other species have been described.
Ivo Pavlik   +3 more
openaire   +3 more sources

Hypersensitivity Pneumonitis Associated with Environmental Mycobacteria [PDF]

open access: yes, 2005
A previously healthy man working as a machine operator in an automotive factory developed respiratory symptoms. Medical evaluation showed abnormal pulmonary function tests, a lung biopsy showed hypersensitivity pneumonitis, and his illness was traced to ...
Akshay Sood   +7 more
core   +2 more sources

Infecções por micobactérias atípicas.

open access: yesActa Médica Portuguesa, 1999
The isolation of nontuberculous mycobacteria was considered for many years as a result of contamination or transient colonization. The role of these bacteria in human disease was recognized only after 1950.
R S Sarmento e Castro   +5 more
doaj   +1 more source

NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice

open access: yesBMC Pulmonary Medicine, 2018
Background In people with cystic fibrosis infection with NonTuberculous Mycobacteria is of increasing prevalence. Mycobacterium abscessus complex is of particular concern and has been associated with adverse clinical outcomes.
Adrien Tissot   +3 more
doaj   +1 more source

Distribution of Nontuberculous Mycobacteria strains [PDF]

open access: yesAnnals of Clinical Microbiology and Antimicrobials, 2013
Mycobacteria other than tuberculosis (MOTT) cause increasingly serious infections especially in immunosuppressive patients by direct transmission from the environment or after colonization. However, identification of these species is difficult because of the cost and difficulties in defining to species level.
Gunaydin, Murat   +6 more
openaire   +4 more sources

The Potential of Digital Polymerase Chain Reaction for Improving Diagnostic Yield of Nontuberculous Mycobacteria Pulmonary Disease

open access: yesInfection and Drug Resistance, 2021
Yoichi Nishii,1 Kazuki Furuhashi,1 Saki Nakamura,1 Miho Nishio,1 Yuki Nakamura,1 Kengo Ushiro,1 Kentaro Ito,1 Tadashi Sakaguchi,1 Yuta Suzuki,1 Kentaro Fujiwara,1 Taro Yasuma,2 Tetsu Kobayashi,3 Corina D’Alessandro-Gabazza,2 Esteban C Gabazza,2 Osamu ...
Nishii Y   +15 more
doaj  

Nontuberculous Mycobacteria in Tap Water [PDF]

open access: yesEmerging Infectious Diseases, 2012
To the Editor: A recently published study by Falkinham (1) showed that 17 (46%) of 37 households were contaminated with nontuberculous mycobacteria (NTM) of the same species as those found in patients with lung disease and that 7 (41%) of 17 had the same DNA fingerprint as the patient.
Eduardo Hernández-Garduño   +1 more
openaire   +3 more sources

Rapid method for Mycobacterium tuberculosis identification using electrospray ionization tandem mass spectrometry analysis of mycolic acids [PDF]

open access: yes, 2013
Mycolic acids (MAs), which play a crucial role in the architecture of mycobacterial cell walls, were analyzed using electrospray ionization tandem mass spectrometry. A targeted analysis based on the 10 most abundant and characteristic multiple reaction
Beata Janiszewska-Drobinska   +38 more
core   +1 more source

Nrf2 Regulates Granuloma Formation and Macrophage Activation during Mycobacterium avium Infection via Mediating Nramp1 and HO-1 Expressions

open access: yesmBio, 2021
Nontuberculous mycobacteria (NTM) are an important cause of morbidity and mortality in pulmonary infections.
Masayuki Nakajima   +12 more
doaj   +1 more source

Nontuberculous Mycobacteria in Cystic Fibrosis [PDF]

open access: yesCurrent Treatment Options in Infectious Diseases, 2016
Nontuberculous mycobacteria (NTM) are found in approximately 10 % of cystic fibrosis (CF) patients, but only a portion will develop NTM disease. The management of CF lung disease should be optimized, including antibiotic therapy targeted to the individual's usual airway bacteria, prior to considering treatment for NTM lung disease.
Gordon Kirkpatrick   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy